Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 45

1.

Rasagiline induced hypersexuality in Parkinson's disease.

Reyes D, Kurako K, Galvez-Jimenez N.

J Clin Neurosci. 2014 Mar;21(3):507-8. doi: 10.1016/j.jocn.2013.04.021. Epub 2013 Sep 20.

PMID:
24055209
[PubMed - in process]
2.

Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease.

Marder K, Gu Y, Eberly S, Tanner CM, Scarmeas N, Oakes D, Shoulson I; Huntington Study Group PHAROS Investigators.

JAMA Neurol. 2013 Nov;70(11):1382-8. doi: 10.1001/jamaneurol.2013.3487.

PMID:
24000094
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Sirsasana (headstand) pose causing compressive myelopathy with myelomalacia.

Ferreira MA, Galvez-Jimenez N.

JAMA Neurol. 2013 Feb;70(2):268. doi: 10.1001/jamaneurol.2013.589. No abstract available.

PMID:
23407666
[PubMed - indexed for MEDLINE]
4.

Tics and Tourette syndrome: an adult perspective.

Galvez-Jimenez N.

Cleve Clin J Med. 2012 Jul;79 Suppl 2:S35-9. doi: 10.3949/ccjm.79.s2a.07.

PMID:
22761269
[PubMed - indexed for MEDLINE]
Free Article
5.

Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.

Pankratz N, Beecham GW, DeStefano AL, Dawson TM, Doheny KF, Factor SA, Hamza TH, Hung AY, Hyman BT, Ivinson AJ, Krainc D, Latourelle JC, Clark LN, Marder K, Martin ER, Mayeux R, Ross OA, Scherzer CR, Simon DK, Tanner C, Vance JM, Wszolek ZK, Zabetian CP, Myers RH, Payami H, Scott WK, Foroud T; PD GWAS Consortium.

Ann Neurol. 2012 Mar;71(3):370-84. doi: 10.1002/ana.22687.

PMID:
22451204
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Current and prospective disease-modifying therapies for amyotrophic lateral sclerosis.

Morren JA, Galvez-Jimenez N.

Expert Opin Investig Drugs. 2012 Mar;21(3):297-320. doi: 10.1517/13543784.2012.657303. Epub 2012 Feb 6. Review.

PMID:
22303913
[PubMed - indexed for MEDLINE]
7.

Copy number variation in familial Parkinson disease.

Pankratz N, Dumitriu A, Hetrick KN, Sun M, Latourelle JC, Wilk JB, Halter C, Doheny KF, Gusella JF, Nichols WC, Myers RH, Foroud T, DeStefano AL; PSG-PROGENI and GenePD Investigators, Coordinators and Molecular Genetic Laboratories.

PLoS One. 2011;6(8):e20988. doi: 10.1371/journal.pone.0020988. Epub 2011 Aug 2.

PMID:
21829596
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Too much, too soon?

Govindarajan R, Galvez-Jimenez N.

Muscle Nerve. 2011 Jul;44(1):149; author reply 149-50. doi: 10.1002/mus.22108. No abstract available.

PMID:
21674531
[PubMed - indexed for MEDLINE]
9.

Awaji Island modified criteria for ALS--increased sensitivity without change in specificity: are they really two sides of the same coin?

Govindarajan R, Galvez-Jimenez N.

Muscle Nerve. 2011 May;43(5):768-9; author reply 769. doi: 10.1002/mus.22027. Epub 2011 Mar 14. No abstract available.

PMID:
21404302
[PubMed - indexed for MEDLINE]
10.

Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts.

Marras C, McDermott MP, Marek K, Rochon P, Naglie G, Tanner CM, Rudolph A, Shoulson I, Lang AE; Parkinson Study Group DATATOP and PRECEPT investigators.

Mov Disord. 2011 Mar;26(4):608-13. doi: 10.1002/mds.23581. Epub 2011 Feb 1.

PMID:
21287602
[PubMed - indexed for MEDLINE]
11.

Where is dihydroergotamine mesylate in the changing landscape of migraine therapy?

Morren JA, Galvez-Jimenez N.

Expert Opin Pharmacother. 2010 Dec;11(18):3085-93. doi: 10.1517/14656566.2010.533839. Review.

PMID:
21080856
[PubMed - indexed for MEDLINE]
12.

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.

Diener HC, Dodick DW, Aurora SK, Turkel CC, DeGryse RE, Lipton RB, Silberstein SD, Brin MF; PREEMPT 2 Chronic Migraine Study Group.

Cephalalgia. 2010 Jul;30(7):804-14. doi: 10.1177/0333102410364677. Epub 2010 Mar 17.

PMID:
20647171
[PubMed - indexed for MEDLINE]
Free Article
13.

Maternal inheritance and mitochondrial DNA variants in familial Parkinson's disease.

Simon DK, Pankratz N, Kissell DK, Pauciulo MW, Halter CA, Rudolph A, Pfeiffer RF, Nichols WC, Foroud T; Parkinson Study Group-PROGENI Investigators.

BMC Med Genet. 2010 Apr 1;11:53. doi: 10.1186/1471-2350-11-53.

PMID:
20356410
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts.

Marras C, Lang AE, Eberly SW, Oakes D, Fahn S, Schwid SR, Hyson C, Shoulson I; Parkinson Study Group DATATOP and PRECEPT investigators.

Mov Disord. 2009 Dec 15;24(16):2370-8. doi: 10.1002/mds.22828.

PMID:
19908310
[PubMed - indexed for MEDLINE]
15.

Genomewide association study for onset age in Parkinson disease.

Latourelle JC, Pankratz N, Dumitriu A, Wilk JB, Goldwurm S, Pezzoli G, Mariani CB, DeStefano AL, Halter C, Gusella JF, Nichols WC, Myers RH, Foroud T; PROGENI Investigators, Coordinators and Molecular Genetic Laboratories; GenePD Investigators, Coordinators and Molecular Genetic Laboratories.

BMC Med Genet. 2009 Sep 22;10:98. doi: 10.1186/1471-2350-10-98.

PMID:
19772629
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

A longitudinal program for biomarker development in Parkinson's disease: a feasibility study.

Ravina B, Tanner C, Dieuliis D, Eberly S, Flagg E, Galpern WR, Fahn S, Goetz CG, Grate S, Kurlan R, Lang AE, Marek K, Kieburtz K, Oakes D, Elliott R, Shoulson I; Parkinson Study Group LABS-PD Investigators.

Mov Disord. 2009 Oct 30;24(14):2081-90. doi: 10.1002/mds.22690.

PMID:
19691116
[PubMed - indexed for MEDLINE]
17.

Dietary intake in adults at risk for Huntington disease: analysis of PHAROS research participants.

Marder K, Zhao H, Eberly S, Tanner CM, Oakes D, Shoulson I; Huntington Study Group.

Neurology. 2009 Aug 4;73(5):385-92. doi: 10.1212/WNL.0b013e3181b04aa2.

PMID:
19652143
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations.

Pankratz N, Kissell DK, Pauciulo MW, Halter CA, Rudolph A, Pfeiffer RF, Marder KS, Foroud T, Nichols WC; Parkinson Study Group-PROGENI Investigators.

Neurology. 2009 Jul 28;73(4):279-86. doi: 10.1212/WNL.0b013e3181af7a33.

PMID:
19636047
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Variation in GIGYF2 is not associated with Parkinson disease.

Nichols WC, Kissell DK, Pankratz N, Pauciulo MW, Elsaesser VE, Clark KA, Halter CA, Rudolph A, Wojcieszek J, Pfeiffer RF, Foroud T; Parkinson Study Group-PROGENI Investigators.

Neurology. 2009 Jun 2;72(22):1886-92. doi: 10.1212/01.wnl.0000346517.98982.1b. Epub 2009 Mar 11.

PMID:
19279319
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset.

Nichols WC, Pankratz N, Marek DK, Pauciulo MW, Elsaesser VE, Halter CA, Rudolph A, Wojcieszek J, Pfeiffer RF, Foroud T; Parkinson Study Group-PROGENI Investigators.

Neurology. 2009 Jan 27;72(4):310-6. doi: 10.1212/01.wnl.0000327823.81237.d1. Epub 2008 Nov 5.

PMID:
18987351
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk